The Globe and Mail reports in its Thursday edition that after Thomson Reuters Nasdaq-listed shares dropped 15.7 per cent on Tuesday on fears that artificial intelligence could threaten its core legal division, Canaccord Genuity analyst Aravinda Galappatthige whacked his share target back to $130 (U.S.) from $174 (U.S.) with an unchanged "buy" recommendation. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $173.24 (U.S.). Mr. Galappatthige says in a note: "From our standpoint, we very much doubt that these offerings impact Thomson's legal products to law firms or even the in-house counsel of larger corporations. We see significant distance between Anthropic's capabilities and Thomson's extensive legal platform. In particular, we note that the breadth of sources that TRI draws content from (circa 3,500) and intensive annotations made on inputted documents (with 1,500 attorneys). Moreover, we note the importance of accuracy in the legal profession, and consequences for errors (or AI hallucinations). Put simply, turning off Westlaw for Claude's legal plug-ins would be tantamount to an investment manager discontinuing Bloomberg or FactSet for the same product."